Accepted Articles > Browse Articles > Accepted Articles



Authors who publish in CMH have an option to make their manuscripts available immediately after acceptance. These “Just Accepted” manuscripts have already been peer-reviewed and approved for publication, but have not yet been proofread or formatted for publication.

When authors choose to take advantage of this CMH service, their papers are uploaded as PDF files with an abstract to the CMHwebsite and available right away to contribute to the research community. When the “Just Accepted” paper is uploaded, this is considered the official publication date, but the “Just Accepted” paper is not considered the final paper of record because the editing process may identify errors to be corrected.

Authors should indicate whether they would like their manuscript uploaded as a “Just Accepted” file when they first submit their paper. It is not possible to change this decision in the middle of the technical editing and formatting process.
A “Just Accepted” manuscript should be cited as an online journal article. To cite a “Just Accepted” manuscript when writing for CMH, follow the guidelines in How to Format the References in the Instructions for Authors section.
Original Article
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
Received March 3, 2023  Accepted March 21, 2023  
View: 235   Download: 25
Review
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: a Japanese perspective
Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi
Received March 12, 2023  Accepted March 20, 2023  
View: 128   Download: 19
Editorial
Challenges in Translating Clinical Practice Guidelines into Real-Life Practice for the management of hepatocellular carcinoma in Taiwan
San-Chi Chen
Received March 11, 2023  Accepted March 17, 2023  
View: 83   Download: 4
Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
Philipp Kasper, Münevver Demir, Hans-Michael Steffen
Received February 15, 2023  Accepted March 16, 2023  
View: 62   Download: 4
Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap
Shen-Yung Wang
Received February 28, 2023  Accepted March 16, 2023  
View: 64   Download: 4
Is liver biopsy mandatory to identify immune-tolerant phase of chronic hepatitis B?
Joo Hyun Oh, Dong Hyun Sinn
Received February 10, 2023  Accepted March 15, 2023  
View: 49   Download: 1
Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
Do Young Kim
Received March 15, 2023  Accepted March 15, 2023  
View: 73   Download: 3
Review
Acute -on- Chronic liver failure – Terminology, Mechanisms and Management
Vinay Kumar BR, Shiv Kumar Sarin
Received April 16, 2022  Accepted February 25, 2023  
View: 139   Download: 25
Editorial
The clinical management of HCC in China: progresses and challenges
Shan Shan, Jidong Jia
Received February 28, 2023  Accepted March 13, 2023  
View: 87   Download: 10
What should be done to reduce the discrepancy between guidelines and real-life practice for HCC in Korea?
Min Kyung Park, Yoon Jun Kim
Received February 28, 2023  Accepted March 14, 2023  
View: 61   Download: 0
The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
Ji-Won Park, Ki Tae Suk
Received March 1, 2023  Accepted March 15, 2023  
View: 82   Download: 12
Management of Hepatocellular Carcinoma in China: Seeking Common Grounds While Reserving Differences
Tian Yang, Ming-Da Wang, Xin-Fei Xu, Chao Li, Han Wu, Feng Shen
Received March 14, 2023  Accepted March 15, 2023  
View: 106   Download: 11
The current trends in the health burden of primary liver cancer across the globe
Peter Konyn, Aijaz Ahmed, Donghee Kim
Received March 4, 2023  Accepted March 11, 2023  
View: 110   Download: 6
Editorial: HCC surveillance in non-alcoholic fatty liver disease – who and how?
Margaret LP Teng, Darren Jun Hao Tan, Cheng Han Ng, Daniel Q. Huang
Received February 23, 2023  Accepted March 13, 2023  
View: 97   Download: 4
Changing the nomenclature from NAFLD to MAFLD is more than a change in terminology
Eileen Laurel Yoon, Dae Won Jun
Received March 1, 2023  Accepted March 13, 2023  
View: 100   Download: 11
Implications of comorbidities in nonalcoholic fatty liver disease
Sherlot Juan Song, Vincent Wai-Sun Wong
Received February 16, 2023  Accepted March 11, 2023  
View: 111   Download: 11
Review
Safety Considerations for Withdrawal of Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B: First, Do No Harm
Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
Received November 26, 2022  Accepted March 13, 2023  
View: 125   Download: 22
Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: Asian perspective comparison
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Received March 9, 2023  Accepted March 9, 2023  
View: 187   Download: 29
Editorial
The prime time for management of hepatocellular carcinoma in Hong Kong
Landon L. Chan, Stephen L. Chan
Received March 7, 2023  Accepted March 8, 2023  
View: 109   Download: 5
The Imitator of Immune-Tolerant Phase in Chronic Hepatitis B: A Killer in Disguise
Moon Haeng Hur, Jeong-Hoon Lee
Received February 28, 2023  Accepted March 7, 2023  
View: 73   Download: 8
Lean vs. obese NAFLD, two phenotypes of NAFLD: look the same but different or vice versa?
Ho Soo Chun, Minjong Lee
Received February 15, 2023  Accepted March 6, 2023  
View: 85   Download: 12
Non-obese or lean nonalcoholic fatty liver disease matters but is it preventable or inevitable in light of its risk factors?
Heejoon Jang, Won Kim
Received March 2, 2023  Accepted March 4, 2023  
View: 140   Download: 12
The latest global burden of liver cancer: A past and present threat
Joo Hyun Oh, Dae Won Jun
Received February 23, 2023  Accepted March 4, 2023  
View: 95   Download: 11
Review
Hepatitis B core-related antigen: a novel and promising surrogate biomarker to guide anti-HBV therapy
Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
Received December 2, 2022  Accepted March 7, 2023  
View: 222   Download: 39
Original Article
Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis
Min Jeong Park, Hayeon Kim, Myeong Gyu Kim, Kyungim Kim
Received October 22, 2022  Accepted March 6, 2023  
View: 174   Download: 18
Analysis of Hepatitis C Virus Resistance-Associated Substitutions in Direct-Acting Antiviral Failure in South Korea Using Next-Generation Sequencing
Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Suk Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong
Received October 28, 2022  Accepted March 1, 2023  
View: 154   Download: 26
Review
A decade of liver organoids: Advancements in disease modeling
Yue Liu, Jian-Ying Sheng, Junjun Ding, Yun-Shen Chan
Received November 29, 2022  Accepted February 28, 2023  
View: 245   Download: 52
Editorial
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
Byeong Geun Song, Dong Hyun Sinn
Received January 5, 2023  Accepted February 27, 2023  
View: 130   Download: 7
The growing burden of non-alcoholic fatty liver disease on mortality
Ju-Yeon Cho, Won Sohn
Received February 28, 2023  Accepted March 2, 2023  
View: 125   Download: 10
Editorial: Noninvasive biomarkers for liver inflammation in NAFLD: current and future
Kee-Huat Chuah, Wah-Kheong Chan
Received February 15, 2023  Accepted February 23, 2023  
View: 120   Download: 10
Original Article
Review
Editorials
Review
Editorials
Reviews
Editorials
Review
Original Articles
Review
Editorials
1 2

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 611
TOTAL : 1211776
Close layer